MedTrace Logo

Safety of Prasaprohyai 95%Ethanolic Extract Capsules in Healthy Volunteer

NCT03077282 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2019-06-26

No results posted yet for this study

Summary

To investigate the safety of Prasaprohyai 95% ethanolic extract at doses of 100 mg and 200 mg for for 6 weeks. (Clinical Trial phase I)

Conditions

  • Healthy Volunteers

Interventions

DRUG

Prasaprohyai

Prasaprohyai 95% ethanolic extract capsules will take three times a day before meals

Sponsors & Collaborators

  • Thai Traditional Medical Knowledge Fund

    collaborator OTHER_GOV

  • Thammasat University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-26
Primary Completion
2018-12-01
Completion
2018-12-14

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03077282 on ClinicalTrials.gov